Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Scorpio2on Oct 12, 2017 11:29pm

145 Views

Post# 26807980

RE:RE:RE:RE:RE:RE:Nasdaq applies to operate stock exchange in Canada

We will only be worth $100++ when TLT is eventually bought out "lock stock and barrell". $5 would be a good valuation to initially recognize (the soon to be) involvement of other pharma(s) on a JV or licensing basis with TLT that also involves money and funding for future clinical trials across a number of indications. As TLT considers and is successful with more trials, the revenue potential will also increase allowing the stock price to rise from $5 to $100++ to potentially some price level that's even higher and consistent with other takeouts KITE etc.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec